臨床血液
Online ISSN : 1882-0824
Print ISSN : 0485-1439
ISSN-L : 0485-1439
臨床研究
造血器悪性腫瘍患者における免疫グロブリン製剤使用の臨床的検討
羽根田 やえ子福士 玄石沢 誠近江 忠尚木村 あさの河村 節子千葉 陽一
著者情報
ジャーナル 認証あり

1980 年 21 巻 8 号 p. 1156-1161

詳細
抄録
Sixty-three patients with hematological malignancy who were admitted into the Department of Internal Medicine, Hirosaki University Hospital, from 1978 to 1979, were investigated. In the siwty-four courses of the concurrent infections gammaglobulin was administered intravenously, courses (59%) the treatment was effective. Gammaglobulin was rather ineffective in sepsis and perianal abscess which were complications of severe underlying diseases. Gammaglobulin was effective in the treatment of the febrile episodes of probable infection without positive blood culture. It was not so effective in eight out of nine elderly patients with pneumonia, which suggested their resistance to infection was low. During the therapeutic course in the hematological malignancies neutropenia was often induced, where gammaglobulin was effective in 57% of severe neutropenia below 100/μl. Lymphocyte count, serum immunoglobulin level and tuberculin reaction were examined, but there was no significant correlation between these data and efficiency of gammaglobulin. Gammaglobulin was more effective when administered within three days from the onset of the febrile episodes. In some cases where there was high risk of infection, preventive administration was given but further investigation is needed to eveluate the effects. No serious side effects of the gammaglobulin preparation were observed.
著者関連情報
© 1980 日本臨床血液学会
前の記事 次の記事
feedback
Top